Indicators of free radical oxidation in neutrophils of patients with primary and recurrent soft tissue sarcomas

Purpose of the study. To carry out a comparative analysis of lipid peroxidation intensity and antioxidant system indices in blood neutrophils of patients with primary and relapsed soft tissue sarcomas (STS) depending on sex and age.

Patients and methods. Of the 81 patients included in the study, 48 had primary STS, 5 patients with continued growth, and 28 patients with recurrent STS. The patients were divided by sex and age; the level of lipid peroxidation products, superoxide dismutase (SOD) activity, total peroxidase activity (TPA), glutathione peroxidase (GPx) activity and reduced glutathione (RG) content in blood neutrophils were investigated by conventional spectrophotometric methods. The comparison groups (donors) consisted of 12 men and 17 women divided into the same age subgroups: ≤ 45 years and > 45 years.

Results. In donors, there was a multiple decrease in the SOD/TPA ratio with age, especially in women, and in men this was accompanied by an age-related decrease in GPx activity. In primary sarcomas in older women and in men with continued growth and recurrence, there was an increase in diene conjugates (DC). In men over 45 years of age, there was an increase in SOD, TPA, and GPx. Women of the older age group were characterized by activation of SOD and GPx, expressed in the relapsed process to a significantly greater extent than in men, and an increase in RG was observed in women. The increase in both components of the glutathione system and SOD activity was especially significant in the development of relapses in women for periods exceeding three years, which was accompanied by a decrease in DC content.

Conclusions. Neutrophils are characterized by an increase in DC content in patients of both sexes in the older age group with primary and recurrent STS, with its highest content in men with continued growth and relapses. GPx activity, increased in both men and women in the older age group in all variants of STS development, may play an important role in the antioxidant protection of blood cells in STS. Thus, the most pronounced activation of GPx, accompanied by a maximum increase in reduced glutathione and activation of SOD, contributes to a decrease in the level of DC and the absence of MDA increase in women with slow development of recurrences.

1. Carnevale S, Ghasemi S, Rigatelli A, Jaillon S. The complexity of neutrophils in health and disease: Focus on cancer. Semin Immunol. 2020 Apr;48:101409. https://doi.org/10.1016/j.smim.2020.101409

2. Sounbuli K, Mironova N, Alekseeva L. Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies. Int J Mol Sci. 2022 Dec 13;23(24):15827. https://doi.org/10.3390/ijms232415827

3. Quail DF, Amulic B, Aziz M, Barnes BJ, Eruslanov E, Fridlender ZG, et al. Neutrophil phenotypes and functions in cancer: A consensus statement. J Exp Med. 2022 Jun 6;219(6):e20220011. https://doi.org/10.1084/jem.20220011

4. Zhu YP, Eggert T, Araujo DJ, Vijayanand P, Ottensmeier CH, Hedrick CC. CyTOF mass cytometry reveals phenotypically distinct human blood neutrophil populations differentially correlated with melanoma stage. J Immunother Cancer. 2020 Sep;8(2):e000473. https://doi.org/10.1136/jitc-2019-000473

5. Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50:1317–1334.e10. https://doi.org/10.1016/j.immuni.2019.03.009

6. Kashyap D, Tuli HS, Sak K, Garg VK, Goel N, Punia S, Chaudhary A. Role of reactive oxygen species in cancer progression. Current Pharmacology Reports 2019;5:79–86. https://doi.org/10.3390/biom9110735

7. Sarmiento-Salinas FL, Perez-Gonzalez A, Acosta-Casique A, Ix-Ballote A, Diaz A, Treviño S, et al. Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression. Life Sci. 2021 Nov 1;284:119942. https://doi.org/10.1016/j.lfs.2021.119942

8. Grünewald TG, Alonso M, Avnet S, Banito A, Burdach S, Cidre-Aranaz F, et al. Sarcoma treatment in the era of molecular medicine. EMBO Mol Med. 2020 Nov 6;12(11):e11131. https://doi.org/10.15252/emmm.201911131

9. Malignant neoplasms in Russia in 2021 (morbidity and mortality). Edited by Kaprin AD, Starinsky VV, Shakhzadova AO. Мoscow: P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation, 2022, 252 p. (In Russ.). Available at: https://glavonco.ru/cancer_register/ЗИС%202021%20 эл.%20версия.pdf, Accessed: 25.10.2023.

10. Saggioro M, D’Angelo E, Bisogno G, Agostini M, Pozzobon M. Carcinoma and sarcoma microenvironment at a glance: Where We are. Front Oncol. 2020;10:76. https://doi.org/10.3389/fonc.2020.00076

11. Ebrahimpour A, Chehrassan M, Sadighi M, Karimi A, Azizmohammad Looha M, Jafari Kafiabadi M. Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis According to National Population-based Study. Arch Bone Jt Surg. 2022 Jan;10(1):67–77. https://doi.org/10.22038/ABJS.2021.53750.2676

12. Gamboa AC, Gronchi A, Cardona K. Soft-tissue sarcoma in adults: An update on the current state of histi type-specifi management in an era of personalized medicine. CA Cancer J Clin. 2020 May;70(3):200–229. https://doi.org/10.3322/caac.21605

13. Roszik J, Mustachio LM, Livingston JA, Groisberg R, Carmagnani Pestana R, Subbiah V, Conley AP. Landscape of immune-related markers and potential therapeutic targets in soft tissue sarcoma. Cancers (Basel) 2021;13(20):5249. https://doi.org/10.3390/cancers13205249

14. Paoliello-Paschoalato AB, Azzolini AE, Cruz MF, Marchi LF, Kabeya LM, Donadi EA, Lucisano-Valim YM. Isolation of healthy individuals’ and rheumatoid arthritis patients’ peripheral blood neutrophils by the gelatin and Ficoll-Hypaque methods: comparative efficiency and impact on the neutrophil oxidative metabolism and Fcγ receptor expression. J Immunol Methods. 2014 Oct;412:70 77. https://doi.org/10.1016/j.jim.2014.07.001

15. Arutynyan AV, Dubinina EE, Zybina NN. Methods for assessing free radical oxidation and the antioxidant system of the body. Guidelines. St. Petersburg: “Foliant” Publ., 2000, 104 p. (In Russ.).

16. Kopylova TN. A new method for the determination of conjugated dienes in blood serum. In: Cellular and subcellular experimental pathology of the liver. Riga, 1982. 135 p. (In Russ.).

17. Lukash AA, Vnukov VV, Ananyan AA, Milyutina NP, Kvasha PN. Metal-containing compounds in blood plasma during hyperbaric oxygenation: Experimental and clinical aspects. Rostov-on-Don, 1996, 108 p. (In Russ.).

18. Goroshinskaya IA, Nerodo GA, Surikova EI, Kachesova PS, Shalashnaya EV, Nerodo EA, et al. Intensity of oxidative processes and state of antioxidant system in patients with different vulvar cancer remission duration. International Journal of Applied and Fundamental Research. 2014;(4):53–56. (In Russ.).

19. Menshenina AP, Goroshinskaya IA, Frantsiyants EM, Moiseenko TI, Verenikina EV, Kaplieva IV, Nemashkalova LA. Effect of dendritic cell vaccine on blood redox status in patients with cervical cancer. Research and Practical Medicine Journal. 2023;10(1):36–49. (In Russ.). https://doi.org/10.17709/2410-1893-2023-10-1-3

20. Popova NN, Goroshinskaya IA, Shikhlyarova AI, Rozenko DA, Menshenina AP, Ardzha AYu, et al. Parameters of free radical oxidation and antioxidant defense in patients with cervical cancer before and after radical surgical treatment. South Russian Journal of Cancer. 2023;4(2):28–38. https://doi.org/10.37748/2686-9039-2023-4-2-3

21. Shalashnaya EV, Goroshinskaya IA, Nerodo GA, Guskova EA, Surikova EI, Nemashkalova LA, et al. Study of the influence of chemotherapy drugs on the level of endogenous intoxication, intensity of free radical oxidation and membrane apparatus of blood cells of patients with cervical cancer recurrence in vitro experiments. Siberian Journal of Oncology. 2008;26(2):50–54. (In Russ.).

22. Goroshinskaya IA, Surikova EI, Frantsiyants EM, Nemashkalova LA, Kachesova PS, Medvedeva DE, Maslov AA. Glutathione-dependent system in the blood of gastric cancer patients with various tumor histotypes and prevalence of the disease. Research and Practical Medicine Journal. 2021;8(4):12–22. (In Russ.). https://doi.org/10.17709/2410-1893-2021-8-4-1

23. Mensurado S, Rei M, Lança T, Ioannou M, Gonçalves-Sousa N, Kubo H, et al. Tumor-Associated Neutrophils Suppress pro-Tumoral IL-17+ Γδ T Cells through Induction of Oxidative Stress. PLoS Biol. 2018;16:e2004990. https://doi.org/10.1371/journal.pbio.2004990

24. Goroshinskaya IA, Kaplieva IV, Frantsiyants EM, Vashchenko LN, Kachesova PS, Lapteva TO, et al. Redox status of blood lymphocytes in patients with soft tissue sarcomas. Bone and soft tissue sarcomas, tumors of the skin. 2023;15(3):21–33. (In Russ.). https://doi.org/10.17650/2782-3687-2023-15-3-21-33